{"protocolSection":{"identificationModule":{"nctId":"NCT03572062","orgStudyIdInfo":{"id":"C3671002"},"secondaryIdInfos":[{"id":"RSV ADJUVANT","type":"OTHER","domain":"Alias Study Number"}],"organization":{"fullName":"Pfizer","class":"INDUSTRY"},"briefTitle":"A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults","officialTitle":"A PHASE 1/2, PLACEBO-CONTROLLED, RANDOMIZED, OBSERVER-BLIND,DOSE-FINDING, FIRST-IN-HUMAN STUDY TO DESCRIBE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF AN ADJUVANTED RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN HEALTHY OLDER ADULTS"},"statusModule":{"statusVerifiedDate":"2021-08","overallStatus":"TERMINATED","whyStopped":"Study halted prematurely by sponsor and will not resume, participants are no longer being examined or receiving intervention.","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2018-06-05","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2020-06-23","type":"ACTUAL"},"completionDateStruct":{"date":"2020-08-19","type":"ACTUAL"},"studyFirstSubmitDate":"2018-06-01","studyFirstSubmitQcDate":"2018-06-18","studyFirstPostDateStruct":{"date":"2018-06-28","type":"ACTUAL"},"resultsFirstSubmitDate":"2021-06-21","resultsFirstSubmitQcDate":"2021-08-25","resultsFirstPostDateStruct":{"date":"2021-08-26","type":"ACTUAL"},"lastUpdateSubmitDate":"2021-08-25","lastUpdatePostDateStruct":{"date":"2021-08-26","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Pfizer","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":true,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The study will evaluate the safety, tolerability, and immunogenicity of up to 7 different RSV vaccine candidates, some with adjuvant, when administered concomitantly with seasonal inactivated influenza vaccine (SIIV) and may evaluate a second dose of RSV vaccine administered12 months after the initial dose.\n\nIn addition the study will evaluate a 2-dose regimen administered 2 months apart to 62 subjects.","detailedDescription":"The study will evaluate the safety, tolerability, and immunogenicity of up to 7 different RSV vaccine candidates, some with adjuvant, when administered concomitantly with SIIV. Healthy male and female subjects between 65 to 85 years of age will be enrolled. Subjects will receive 2 intramuscular injections to assess the concomitant administration of SIIV when given to subjects receiving one of the 3 RSV vaccine dose-level candidates formulated with or without an adjuvant.\n\nIf interim support implementation of revaccination, invited, consenting subjects will be revaccinated with the same dose and formulation of the RSV vaccine or placebo received at Visit 1, concomitantly with SIIV. The safety, tolerability, and immunogenicity of the second dose will be evaluated through 12 months after revaccination.\n\n62 subjects will be randomized 1:1 to receive a dose of high dose adjuvanted RSV vaccine or placebo followed by a second dose 2 months later. Safety, tolerability, and immunogenicity will be evaluated. The subjects will be enrolled before the influenza season. There will be no concomitant SIIV administration."},"conditionsModule":{"conditions":["Respiratory Tract Infection"],"keywords":["Respiratory tract infection, RSV, Adjuvant, vaccine"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","interventionModelDescription":"Parallel","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"QUADRUPLE","maskingDescription":"Observer blind","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":317,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"Arm 1","type":"EXPERIMENTAL","description":"Low dose formulation A and SIIV","interventionNames":["Biological: Formulation A"]},{"label":"Arm 2","type":"EXPERIMENTAL","description":"Low dose formulation B and SIIV","interventionNames":["Biological: Formulation B"]},{"label":"Arm 3","type":"EXPERIMENTAL","description":"Mid dose formulation A and SIIV","interventionNames":["Biological: Formulation A"]},{"label":"Arm 4","type":"EXPERIMENTAL","description":"Mid dose formulation B and SIIV","interventionNames":["Biological: Formulation B"]},{"label":"Arm 5","type":"EXPERIMENTAL","description":"High dose formulation A and SIIV","interventionNames":["Biological: Formulation A"]},{"label":"Arm 6","type":"EXPERIMENTAL","description":"High dose formulation B and SIIV","interventionNames":["Biological: Formulation B"]},{"label":"Arm 7","type":"EXPERIMENTAL","description":"High dose formulation C and SIIV","interventionNames":["Biological: Formulation C"]},{"label":"Arm 8","type":"PLACEBO_COMPARATOR","description":"Placebo and SIIV","interventionNames":["Biological: Placebo"]},{"label":"M0M2 Arm 1","type":"EXPERIMENTAL","description":"High dose formulation B","interventionNames":["Biological: Formulation B"]},{"label":"M0M2 Arm 2","type":"PLACEBO_COMPARATOR","description":"Placebo","interventionNames":["Biological: Placebo"]}],"interventions":[{"type":"BIOLOGICAL","name":"Formulation A","description":"RSV vaccine","armGroupLabels":["Arm 1","Arm 3","Arm 5"]},{"type":"BIOLOGICAL","name":"Formulation B","description":"Adjuvanted RSV vaccine","armGroupLabels":["Arm 2","Arm 4","Arm 6","M0M2 Arm 1"]},{"type":"BIOLOGICAL","name":"Formulation C","description":"RSV vaccine","armGroupLabels":["Arm 7"]},{"type":"BIOLOGICAL","name":"Placebo","description":"Placebo","armGroupLabels":["Arm 8","M0M2 Arm 2"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Primary Cohort: Percentage of Participants With Local Reactions Within 14 Days After Vaccination 1","description":"Local reactions included redness, swelling, and pain at the injection site (left arm) recorded by participants in an electronic diary (e-diary). Redness and swelling were measured and recorded in measuring device units (range: 1 to 20, and greater than \\[\\>\\] 21). 1 measuring device unit = 0.5 centimeter (cm) and graded as: mild (2.5 to 5.0 cm), moderate (greater than \\[\\>\\] 5.0 to 10.0 cm), and severe (\\>10 cm). Pain at injection site was graded as: mild (did not interfere with activity), moderate (interferes with activity) and severe (prevented daily activity).","timeFrame":"Within 14 days after Vaccination 1"},{"measure":"Primary Cohort: Percentage of Participants With Systemic Events Within 14 Days After Vaccination 1","description":"Systemic events included fever, fatigue/tiredness, headache, vomiting, nausea, diarrhea, muscle pain and joint pain recorded by participants in an e-diary. Fever was graded as: mild (38.0 to 38.4 degrees \\[deg\\] Celsius \\[C\\]), moderate (38.5 to 38.9 deg C), severe (39 deg C to 40.0 deg C) and grade 4 (\\>40.0 deg C). Fatigue, headache, nausea, muscle and joint pain were graded as: mild (did not interfere with activity), moderate (some interference with activity) and severe (prevented daily routine activity). Vomiting was graded as: mild (1-2 times in 24 hours \\[h\\]), moderate (\\>2 times in 24h) and severe (required intravenous hydration). Diarrhea was graded as: mild (2-3 loose stools in 24h), moderate (4-5 loose stools in 24h) and severe (6 or more loose stools in 24h).","timeFrame":"Within 14 days after Vaccination 1"},{"measure":"Primary Cohort: Percentage of Participants With Adverse Events (AEs) Within 1 Month After Vaccination 1","description":"An AE is any untoward medical occurrence in a study participant administered a product or medical device; the event need not necessarily have a causal relationship with the treatment or usage. AEs included both serious and non-serious adverse events.","timeFrame":"Within 1 month after Vaccination 1"},{"measure":"Primary Cohort: Percentage of Participants With Medically Attended Adverse Events (MAEs) and Serious Adverse Events (SAEs) Through 12 Months After Vaccination 1","description":"An MAE was defined as a non-serious AE that resulted in an evaluation at a medical facility. A SAE is any untoward medical occurrence at any dose: results in death; is life-threatening (immediate risk of death); requires inpatient hospitalization or prolongation of existing hospitalization; results in persistent or significant disability/incapacity (substantial disruption of the ability to conduct normal life functions); results in congenital anomaly/birth defect.","timeFrame":"Up to 12 months after Vaccination 1"}],"secondaryOutcomes":[{"measure":"Primary Cohort: Geometric Mean Titers (GMT) of Respiratory Syncytial Virus Subgroup A (RSV A) and Respiratory Syncytial Virus Subgroup B (RSV B) Neutralizing Antibodies Before and 1 Month After Vaccination 1","description":"GMTs of RSV A and RSV B antigens were measured using neutralizing assay. Titers above the lower limit of quantitation (LLOQ) were considered accurate and their quantitated values were reported. The neutralizing titer LLOQ values were: A = 50 and B = 70. Assay results below the LLOQ were set to 0.5 × LLOQ.","timeFrame":"Before vaccination and 1 Month after Vaccination 1"},{"measure":"Primary Cohort: Hemagglutination Inhibition Assay (HAI) and Neutralizing Antibody Geometric Mean Titers for All Strains Following the Seasonal Inactivated Influenza Vaccine (SIIV) Before and 1 Month After Vaccination 1","description":"The HAI and neutralizing titer LLOQ value for each strain was 1:10. Assay results below the LLOQ were set to 0.5 × LLOQ. The analysis was performed on following strains: H1N1 A/Michigan, H3N2 A/Brisbane, B/Phuket for HAI and H3N2/Brisbane for neutralizing assay.","timeFrame":"Before vaccination and 1 Month after Vaccination 1"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Evidence of a personally signed and dated informed consent document (ICD) indicating that the subject has been informed of all pertinent aspects of the study.\n2. Healthy adults who are determined by medical history, physical examination, and clinical judgment of the investigator to be eligible for inclusion in the study.\n3. Willing and able to comply with scheduled visits, vaccination plan, laboratory tests, and other study procedures.\n4. Male and nonchildbearing-potential female adults aged 65 to 85 years at the time of enrollment (signing of the ICD).\n5. Subjects must have received the primary vaccination (RSV vaccine or placebo) at Visit 1 and have signed and dated the ICD for participating in the revaccination stage (applies to Primary Study Cohort - Stage 2 subjects).\n\nExclusion Criteria:\n\n1. Investigator site staff members directly involved in the conduct of the study and their family members, site staff members otherwise supervised by the investigator, or subjects who are Pfizer employees, including their family members, directly involved in the conduct of the study.\n2. Participation in other studies involving investigational product within 28 days prior to study entry and/or during study participation.\n3. Known infection with HIV, hepatitis C virus (HCV), or hepatitis B virus (HBV).\n4. Previous vaccination with any licensed or investigational RSV vaccine before enrollment into the study, or planned receipt throughout the study of nonstudy RSV vaccine.\n5. Vaccination with any influenza vaccine within 6 months (182 days) before investigational product administration (applies to Primary Study Cohort - Stages 1 and 2).\n6. History of severe adverse reaction associated with a vaccine and/or severe allergic reaction (eg, anaphylaxis) to any component of the investigational product(s), including natural rubber latex. In addition, a history of severe allergic reaction (eg, anaphylaxis) to any substance, including documented allergy to egg proteins (egg or egg products) or chicken proteins.\n7. Subjects with known or suspected immunodeficiency, as determined by history and/or laboratory/physical examination.\n8. Subjects who receive treatment with immunosuppressive therapy, including cytotoxic agents or systemic corticosteroids, eg, for cancer or an autoimmune disease, or planned receipt throughout the study. If systemic corticosteroids have been administered short term (\\<14 days) for treatment of an acute illness, subjects should not be enrolled into the study until corticosteroid therapy has been discontinued for at least 28 days before investigational product administration.Inhaled/nebulized, intra-articular, intrabursal, or topical (epidural, skin or eyes) corticosteroids are permitted.\n9. Subject with a history of autoimmune disease or an active autoimmune disease requiring therapeutic intervention including but not limited to: systemic or cutaneous lupus erythematosus, autoimmune arthritis/rheumatoid arthritis, Guillain-Barré syndrome,multiple sclerosis, Sjögren syndrome, idiopathic thrombocytopenic purpura, autoimmune glomerulonephritis, autoimmune thyroiditis, giant cell arteritis (temporal arteritis), psoriasis, and insulin-dependent diabetes mellitus (type 1).\n10. Receipt of blood/plasma products or immunoglobulin, from 60 days before investigational product administration or planned receipt throughout the study.\n11. Bleeding diathesis or condition associated with prolonged bleeding that would, in the opinion of the investigator, contraindicate intramuscular injection.\n12. Female subjects of childbearing potential or who are pregnant or breastfeeding; fertile male subjects who are unwilling to use a highly effective method of contraception for at least 28 days after the last dose of investigational product.\n13. Other acute or chronic medical or psychiatric condition including recent (within the past year) or active suicidal ideation or behavior or laboratory abnormality that may increase the risk associated with study participation or investigational product administration or may interfere with the interpretation of study results and, in the judgment of the investigator, would make the subject inappropriate for entry into this study.\n14. Planned donation of blood volumes of approximately 470 mL within 12 weeks after Vaccination 1 (applies to subjects having additional blood drawn for cellular assays).","healthyVolunteers":true,"sex":"ALL","minimumAge":"65 Years","maximumAge":"85 Years","stdAges":["OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Pfizer CT.gov Call Center","affiliation":"Pfizer","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"Qps Mra, Llc","city":"South Miami","state":"Florida","zip":"33143","country":"United States","geoPoint":{"lat":25.7076,"lon":-80.29338}},{"facility":"Optimal Research, LLC","city":"Peoria","state":"Illinois","zip":"61614","country":"United States","geoPoint":{"lat":40.69365,"lon":-89.58899}},{"facility":"Synexus Clinical Research US","city":"Fremont","state":"Nebraska","zip":"68025","country":"United States","geoPoint":{"lat":41.43333,"lon":-96.49808}},{"facility":"Quality Clinical Research, Inc.","city":"Omaha","state":"Nebraska","zip":"68114","country":"United States","geoPoint":{"lat":41.25626,"lon":-95.94043}},{"facility":"Australian Clinical Research Network","city":"Maroubra","state":"New South Wales","zip":"2035","country":"Australia","geoPoint":{"lat":-33.95,"lon":151.23333}},{"facility":"AIM Centre (Hunter Diabetes Centre)","city":"Merewether","state":"New South Wales","zip":"2291","country":"Australia","geoPoint":{"lat":-32.94801,"lon":151.74325}},{"facility":"Holdsworth House Medical Practice","city":"Sydney","state":"New South Wales","zip":"2010","country":"Australia","geoPoint":{"lat":-33.86785,"lon":151.20732}},{"facility":"Westmead Hospital (Infectious Diseases and Microbiology)","city":"Westmead","state":"New South Wales","zip":"2145","country":"Australia","geoPoint":{"lat":-33.80383,"lon":150.98768}},{"facility":"Data Health Australia Pty Limited (Trading as AusTrials)","city":"Taringa","state":"Queensland","zip":"4068","country":"Australia","geoPoint":{"lat":-27.49061,"lon":152.97861}},{"facility":"Eastern Health","city":"Box Hill","state":"Victoria","zip":"3128","country":"Australia","geoPoint":{"lat":-37.81887,"lon":145.12545}},{"facility":"Emeritus Research Pty. Ltd.","city":"Camberwell","state":"Victoria","zip":"3124","country":"Australia","geoPoint":{"lat":-37.84205,"lon":145.0694}},{"facility":"Monash Medical Centre","city":"Clayton","state":"Victoria","zip":"3168","country":"Australia","geoPoint":{"lat":-37.91667,"lon":145.11667}},{"facility":"Barwon Health","city":"Geelong","state":"Victoria","zip":"3220","country":"Australia","geoPoint":{"lat":-38.14711,"lon":144.36069}},{"facility":"Doctors of Ivanhoe","city":"Ivanhoe","state":"Victoria","zip":"3079","country":"Australia","geoPoint":{"lat":-37.76903,"lon":145.04308}},{"facility":"Institute for Respiratory Health","city":"Nedlands","state":"Western Australia","zip":"6009","country":"Australia","geoPoint":{"lat":-31.98184,"lon":115.8073}},{"facility":"TrialsWest","city":"Spearwood","state":"Western Australia","zip":"6163","country":"Australia","geoPoint":{"lat":-32.10534,"lon":115.77797}}]},"referencesModule":{"references":[{"pmid":"35543281","type":"DERIVED","citation":"Baber J, Arya M, Moodley Y, Jaques A, Jiang Q, Swanson KA, Cooper D, Maddur MS, Loschko J, Gurtman A, Jansen KU, Gruber WC, Dormitzer PR, Schmoele-Thoma B. A Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine With and Without Adjuvant in Healthy Older Adults. J Infect Dis. 2022 Dec 13;226(12):2054-2063. doi: 10.1093/infdis/jiac189."}],"seeAlsoLinks":[{"label":"To obtain contact information for a study center near you, click here.","url":"https://pmiform.com/clinical-trial-info-request?StudyID=C3671002"}]},"ipdSharingStatementModule":{"ipdSharing":"YES","description":"Pfizer will provide access to individual de-identified participant data and related study documents (e.g. protocol, Statistical Analysis Plan (SAP), Clinical Study Report (CSR)) upon request from qualified researchers, and subject to certain criteria, conditions, and exceptions. Further details on Pfizer's data sharing criteria and process for requesting access can be found at: https://www.pfizer.com/science/clinical\\_trials/trial\\_data\\_and\\_results/data\\_requests.","url":"https://www.pfizer.com/science/clinical_trials/trial_data_and_results/data_requests"}},"resultsSection":{"participantFlowModule":{"preAssignmentDetails":"This study was conducted in 2 Cohorts: Primary Cohort (Single administration of RSVpreF formulations or placebo, co-administered with seasonal inactivated influenza vaccine \\[SIIV\\]), and Month-0, Month-2 Cohort (two doses of an RSVpreF formulation or placebo administered two months apart).","groups":[{"id":"FG000","title":"Primary Cohort: RSVpreF 60 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of respiratory syncytial virus stabilized prefusion F subunit (RSVpreF) 60 microgram (mcg) with aluminum hydroxide (Al\\[OH\\]3) by injecting 0.5 milliliter (mL) dose along with single 0.5mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"FG001","title":"Primary Cohort: RSVpreF 60 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 60 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"FG002","title":"Primary Cohort: RSVpreF 120 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 120 mcg with Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"FG003","title":"Primary Cohort: RSVpreF 120 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 120 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"FG004","title":"Primary Cohort: RSVpreF 240 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"FG005","title":"Primary Cohort: RSVpreF 240 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"FG006","title":"Primary Cohort: RSVpreF 240 mcg + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"FG007","title":"Primary Cohort: Placebo + SIIV","description":"Participants were administered an intramuscular dose of placebo intramuscularly as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"FG008","title":"Month-0, Month-2 Cohort: RSVpreF 240 mcg + CpG/Al(OH)3","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with CpG/Al(OH)3 as 0.5-mL injection on Day 1 Month 0 (Vaccination 1) and Month 2 (Vaccination 2: 54 to 66 Days after Vaccination 1). Participants were followed up through 6 months after Vaccination 2."},{"id":"FG009","title":"Month-0, Month-2 Cohort: Placebo","description":"Participants were administered an intramuscular dose of placebo as 0.5-mL injection on Day 1 Month 0 (Vaccination 1) and Month 2 (Vaccination 2: 54 to 66 Days after Vaccination 1). Participants were followed up through 6 months after Vaccination 2."}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"32"},{"groupId":"FG001","numSubjects":"32"},{"groupId":"FG002","numSubjects":"32"},{"groupId":"FG003","numSubjects":"31"},{"groupId":"FG004","numSubjects":"32"},{"groupId":"FG005","numSubjects":"32"},{"groupId":"FG006","numSubjects":"32"},{"groupId":"FG007","numSubjects":"31"},{"groupId":"FG008","numSubjects":"32"},{"groupId":"FG009","numSubjects":"31"}]},{"type":"Treated","achievements":[{"groupId":"FG000","numSubjects":"32"},{"groupId":"FG001","numSubjects":"32"},{"groupId":"FG002","numSubjects":"32"},{"groupId":"FG003","numSubjects":"31"},{"groupId":"FG004","numSubjects":"31"},{"groupId":"FG005","numSubjects":"30"},{"groupId":"FG006","numSubjects":"32"},{"groupId":"FG007","numSubjects":"30"},{"groupId":"FG008","numSubjects":"32"},{"groupId":"FG009","numSubjects":"31"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"32"},{"groupId":"FG001","numSubjects":"32"},{"groupId":"FG002","numSubjects":"32"},{"groupId":"FG003","numSubjects":"31"},{"groupId":"FG004","numSubjects":"31"},{"groupId":"FG005","numSubjects":"28"},{"groupId":"FG006","numSubjects":"31"},{"groupId":"FG007","numSubjects":"30"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"1"},{"groupId":"FG005","numSubjects":"4"},{"groupId":"FG006","numSubjects":"1"},{"groupId":"FG007","numSubjects":"1"},{"groupId":"FG008","numSubjects":"32"},{"groupId":"FG009","numSubjects":"31"}]}],"dropWithdraws":[{"type":"Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"1"},{"groupId":"FG009","numSubjects":"3"}]},{"type":"Death","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"1"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"1"},{"groupId":"FG006","numSubjects":"1"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"}]},{"type":"No Longer Meets Eligibility Criteria","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"1"},{"groupId":"FG009","numSubjects":"0"}]},{"type":"Study Terminated By Sponsor","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"29"},{"groupId":"FG009","numSubjects":"27"}]},{"type":"Physician Decision","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"1"},{"groupId":"FG009","numSubjects":"0"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"1"}]},{"type":"Randomized But Not Treated","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"1"},{"groupId":"FG005","numSubjects":"2"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"1"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"}]}]}]},"baselineCharacteristicsModule":{"populationDescription":"Safety population included all participants who received at least 1 dose of the investigational products (RSVpreF or placebo) at Visit 1.","groups":[{"id":"BG000","title":"Primary Cohort: RSVpreF 60 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of respiratory syncytial virus stabilized prefusion F subunit (RSVpreF) 60 microgram (mcg) with aluminum hydroxide (Al\\[OH\\]3) by injecting 0.5 milliliter (mL) dose along with single 0.5mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"BG001","title":"Primary Cohort: RSVpreF 60 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 60 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"BG002","title":"Primary Cohort: RSVpreF 120 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 120 mcg with Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"BG003","title":"Primary Cohort: RSVpreF 120 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 120 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"BG004","title":"Primary Cohort: RSVpreF 240 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"BG005","title":"Primary Cohort: RSVpreF 240 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"BG006","title":"Primary Cohort: RSVpreF 240 mcg + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"BG007","title":"Primary Cohort: Placebo + SIIV","description":"Participants were administered an intramuscular dose of placebo intramuscularly as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"BG008","title":"Month-0, Month-2 Cohort: RSVpreF 240 mcg + CpG/Al(OH)3","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with CpG/Al(OH)3 as 0.5-mL injection on Day 1 Month 0 (Vaccination 1) and Month 2 (Vaccination 2: 54 to 66 Days after Vaccination 1). Participants were followed up through 6 months after Vaccination 2."},{"id":"BG009","title":"Month-0, Month-2 Cohort: Placebo","description":"Participants were administered an intramuscular dose of placebo as 0.5-mL injection on Day 1 Month 0 (Vaccination 1) and Month 2 (Vaccination 2: 54 to 66 Days after Vaccination 1). Participants were followed up through 6 months after Vaccination 2."},{"id":"BG010","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"32"},{"groupId":"BG001","value":"32"},{"groupId":"BG002","value":"32"},{"groupId":"BG003","value":"31"},{"groupId":"BG004","value":"31"},{"groupId":"BG005","value":"30"},{"groupId":"BG006","value":"32"},{"groupId":"BG007","value":"30"},{"groupId":"BG008","value":"32"},{"groupId":"BG009","value":"31"},{"groupId":"BG010","value":"313"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"years","classes":[{"title":"Mean","categories":[{"measurements":[{"groupId":"BG000","value":"71.2","spread":"5.4"},{"groupId":"BG001","value":"71.0","spread":"4.8"},{"groupId":"BG002","value":"72.3","spread":"4.5"},{"groupId":"BG003","value":"70.2","spread":"4.3"},{"groupId":"BG004","value":"71.4","spread":"5.3"},{"groupId":"BG005","value":"70.2","spread":"3.5"},{"groupId":"BG006","value":"70.4","spread":"5.4"},{"groupId":"BG007","value":"70.8","spread":"4.5"},{"groupId":"BG008","value":"72.2","spread":"4.4"},{"groupId":"BG009","value":"72.6","spread":"5.4"},{"groupId":"BG010","value":"71.2","spread":"4.8"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"17"},{"groupId":"BG003","value":"16"},{"groupId":"BG004","value":"13"},{"groupId":"BG005","value":"11"},{"groupId":"BG006","value":"12"},{"groupId":"BG007","value":"14"},{"groupId":"BG008","value":"16"},{"groupId":"BG009","value":"17"},{"groupId":"BG010","value":"145"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"15"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"15"},{"groupId":"BG003","value":"15"},{"groupId":"BG004","value":"18"},{"groupId":"BG005","value":"19"},{"groupId":"BG006","value":"20"},{"groupId":"BG007","value":"16"},{"groupId":"BG008","value":"16"},{"groupId":"BG009","value":"14"},{"groupId":"BG010","value":"168"}]}]}]},{"title":"Ethnicity (NIH/OMB)","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Hispanic or Latino","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"1"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"1"}]},{"title":"Not Hispanic or Latino","measurements":[{"groupId":"BG000","value":"32"},{"groupId":"BG001","value":"32"},{"groupId":"BG002","value":"32"},{"groupId":"BG003","value":"31"},{"groupId":"BG004","value":"30"},{"groupId":"BG005","value":"30"},{"groupId":"BG006","value":"32"},{"groupId":"BG007","value":"30"},{"groupId":"BG008","value":"32"},{"groupId":"BG009","value":"31"},{"groupId":"BG010","value":"312"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"0"}]}]}]},{"title":"Race/Ethnicity, Customized","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"title":"Race","categories":[{"title":"Asian","measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"1"},{"groupId":"BG005","value":"3"},{"groupId":"BG006","value":"4"},{"groupId":"BG007","value":"4"},{"groupId":"BG008","value":"1"},{"groupId":"BG009","value":"2"},{"groupId":"BG010","value":"23"}]},{"title":"White","measurements":[{"groupId":"BG000","value":"30"},{"groupId":"BG001","value":"30"},{"groupId":"BG002","value":"29"},{"groupId":"BG003","value":"29"},{"groupId":"BG004","value":"29"},{"groupId":"BG005","value":"27"},{"groupId":"BG006","value":"26"},{"groupId":"BG007","value":"25"},{"groupId":"BG008","value":"31"},{"groupId":"BG009","value":"29"},{"groupId":"BG010","value":"285"}]},{"title":"Black or African American","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"1"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"1"}]},{"title":"Unknown or Not Reported","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"1"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"2"},{"groupId":"BG007","value":"1"},{"groupId":"BG008","value":"0"},{"groupId":"BG009","value":"0"},{"groupId":"BG010","value":"4"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Primary Cohort: Percentage of Participants With Local Reactions Within 14 Days After Vaccination 1","description":"Local reactions included redness, swelling, and pain at the injection site (left arm) recorded by participants in an electronic diary (e-diary). Redness and swelling were measured and recorded in measuring device units (range: 1 to 20, and greater than \\[\\>\\] 21). 1 measuring device unit = 0.5 centimeter (cm) and graded as: mild (2.5 to 5.0 cm), moderate (greater than \\[\\>\\] 5.0 to 10.0 cm), and severe (\\>10 cm). Pain at injection site was graded as: mild (did not interfere with activity), moderate (interferes with activity) and severe (prevented daily activity).","populationDescription":"Safety population included all participants who received at least 1 dose of the investigational products (RSVpreF or placebo) at Visit 1. Here, \"Overall Number of Participants Analyzed\" signifies participants evaluable for this outcome measure. Data for this outcome measure was planned to be collected for Primary cohort only.","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"percentage of participants","timeFrame":"Within 14 days after Vaccination 1","groups":[{"id":"OG000","title":"Primary Cohort: RSVpreF 60 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of respiratory syncytial virus stabilized prefusion F subunit (RSVpreF) 60 microgram (mcg) with aluminum hydroxide (Al\\[OH\\]3) by injecting 0.5 milliliter (mL) dose along with single 0.5mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG001","title":"Primary Cohort: RSVpreF 60 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 60 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG002","title":"Primary Cohort: RSVpreF 120 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 120 mcg with Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG003","title":"Primary Cohort: RSVpreF 120 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 120 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG004","title":"Primary Cohort: RSVpreF 240 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG005","title":"Primary Cohort: RSVpreF 240 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG006","title":"Primary Cohort: RSVpreF 240 mcg + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG007","title":"Primary Cohort: Placebo + SIIV","description":"Participants were administered an intramuscular dose of placebo intramuscularly as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"31"},{"groupId":"OG005","value":"30"},{"groupId":"OG006","value":"32"},{"groupId":"OG007","value":"30"}]}],"classes":[{"title":"Pain at Injection Site: Mild","categories":[{"measurements":[{"groupId":"OG000","value":"32.3","lowerLimit":"16.7","upperLimit":"51.4"},{"groupId":"OG001","value":"28.1","lowerLimit":"13.7","upperLimit":"46.7"},{"groupId":"OG002","value":"3.1","lowerLimit":"0.1","upperLimit":"16.2"},{"groupId":"OG003","value":"25.8","lowerLimit":"11.9","upperLimit":"44.6"},{"groupId":"OG004","value":"22.6","lowerLimit":"9.6","upperLimit":"41.1"},{"groupId":"OG005","value":"16.7","lowerLimit":"5.6","upperLimit":"34.7"},{"groupId":"OG006","value":"18.8","lowerLimit":"7.2","upperLimit":"36.4"},{"groupId":"OG007","value":"6.7","lowerLimit":"0.8","upperLimit":"22.1"}]}]},{"title":"Pain at Injection Site: Moderate","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG001","value":"3.1","lowerLimit":"0.1","upperLimit":"16.2"},{"groupId":"OG002","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG003","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG004","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG007","value":"3.3","lowerLimit":"0.1","upperLimit":"17.2"}]}]},{"title":"Pain at Injection Site: Severe","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG003","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG004","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG007","value":"0","lowerLimit":"0.0","upperLimit":"11.6"}]}]},{"title":"Redness: Mild","categories":[{"measurements":[{"groupId":"OG000","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"3.1","lowerLimit":"0.1","upperLimit":"16.2"},{"groupId":"OG003","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG004","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"3.1","lowerLimit":"0.1","upperLimit":"16.2"},{"groupId":"OG007","value":"0","lowerLimit":"0.0","upperLimit":"11.6"}]}]},{"title":"Redness: Moderate","categories":[{"measurements":[{"groupId":"OG000","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG003","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG004","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"3.1","lowerLimit":"0.1","upperLimit":"16.2"},{"groupId":"OG007","value":"0","lowerLimit":"0.0","upperLimit":"11.6"}]}]},{"title":"Redness: Severe","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG003","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG004","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG007","value":"0","lowerLimit":"0.0","upperLimit":"11.6"}]}]},{"title":"Swelling: Mild","categories":[{"measurements":[{"groupId":"OG000","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG001","value":"3.1","lowerLimit":"0.1","upperLimit":"16.2"},{"groupId":"OG002","value":"3.1","lowerLimit":"0.1","upperLimit":"16.2"},{"groupId":"OG003","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG004","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG007","value":"3.3","lowerLimit":"0.1","upperLimit":"17.2"}]}]},{"title":"Swelling: Moderate","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG003","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG004","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG007","value":"0","lowerLimit":"0.0","upperLimit":"11.6"}]}]},{"title":"Swelling: Severe","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG003","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG004","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG007","value":"0","lowerLimit":"0.0","upperLimit":"11.6"}]}]}]},{"type":"PRIMARY","title":"Primary Cohort: Percentage of Participants With Systemic Events Within 14 Days After Vaccination 1","description":"Systemic events included fever, fatigue/tiredness, headache, vomiting, nausea, diarrhea, muscle pain and joint pain recorded by participants in an e-diary. Fever was graded as: mild (38.0 to 38.4 degrees \\[deg\\] Celsius \\[C\\]), moderate (38.5 to 38.9 deg C), severe (39 deg C to 40.0 deg C) and grade 4 (\\>40.0 deg C). Fatigue, headache, nausea, muscle and joint pain were graded as: mild (did not interfere with activity), moderate (some interference with activity) and severe (prevented daily routine activity). Vomiting was graded as: mild (1-2 times in 24 hours \\[h\\]), moderate (\\>2 times in 24h) and severe (required intravenous hydration). Diarrhea was graded as: mild (2-3 loose stools in 24h), moderate (4-5 loose stools in 24h) and severe (6 or more loose stools in 24h).","populationDescription":"Safety population included all participants who received at least 1 dose of the investigational products (RSVpreF or placebo) at Visit 1. Here, \"Overall Number of Participants Analyzed\" signifies participants evaluable for this outcome measure. Data for this outcome measure was planned to be collected for Primary cohort only.","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"percentage of participants","timeFrame":"Within 14 days after Vaccination 1","groups":[{"id":"OG000","title":"Primary Cohort: RSVpreF 60 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of respiratory syncytial virus stabilized prefusion F subunit (RSVpreF) 60 microgram (mcg) with aluminum hydroxide (Al\\[OH\\]3) by injecting 0.5 milliliter (mL) dose along with single 0.5mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG001","title":"Primary Cohort: RSVpreF 60 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 60 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG002","title":"Primary Cohort: RSVpreF 120 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 120 mcg with Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG003","title":"Primary Cohort: RSVpreF 120 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 120 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG004","title":"Primary Cohort: RSVpreF 240 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG005","title":"Primary Cohort: RSVpreF 240 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG006","title":"Primary Cohort: RSVpreF 240 mcg + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG007","title":"Primary Cohort: Placebo + SIIV","description":"Participants were administered an intramuscular dose of placebo intramuscularly as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"31"},{"groupId":"OG005","value":"30"},{"groupId":"OG006","value":"32"},{"groupId":"OG007","value":"30"}]}],"classes":[{"title":"Fever: Mild","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"9.4","lowerLimit":"2.0","upperLimit":"25.0"},{"groupId":"OG003","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG004","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG007","value":"0","lowerLimit":"0.0","upperLimit":"11.6"}]}]},{"title":"Fever: Moderate","categories":[{"measurements":[{"groupId":"OG000","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG003","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG004","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG007","value":"0","lowerLimit":"0.0","upperLimit":"11.6"}]}]},{"title":"Fever: Severe","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG003","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG004","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG007","value":"0","lowerLimit":"0.0","upperLimit":"11.6"}]}]},{"title":"Fever: Grade 4","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG003","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG004","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG007","value":"0","lowerLimit":"0.0","upperLimit":"11.6"}]}]},{"title":"Nausea: Mild","categories":[{"measurements":[{"groupId":"OG000","value":"9.7","lowerLimit":"2.0","upperLimit":"25.8"},{"groupId":"OG001","value":"3.1","lowerLimit":"0.1","upperLimit":"16.2"},{"groupId":"OG002","value":"3.1","lowerLimit":"0.1","upperLimit":"16.2"},{"groupId":"OG003","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG004","value":"6.5","lowerLimit":"0.8","upperLimit":"21.4"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"6.3","lowerLimit":"0.8","upperLimit":"20.8"},{"groupId":"OG007","value":"10.0","lowerLimit":"2.1","upperLimit":"26.5"}]}]},{"title":"Nausea: Moderate","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG003","value":"6.5","lowerLimit":"0.8","upperLimit":"21.4"},{"groupId":"OG004","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG007","value":"0","lowerLimit":"0.0","upperLimit":"11.6"}]}]},{"title":"Nausea: Severe","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG003","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG004","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG007","value":"0","lowerLimit":"0.0","upperLimit":"11.6"}]}]},{"title":"Vomiting: Mild","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG003","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG004","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG007","value":"0","lowerLimit":"0.0","upperLimit":"11.6"}]}]},{"title":"Vomiting: Moderate","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG003","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG004","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG007","value":"0","lowerLimit":"0.0","upperLimit":"11.6"}]}]},{"title":"Vomiting: Severe","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG003","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG004","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG007","value":"00","lowerLimit":"0.0","upperLimit":"11.6"}]}]},{"title":"Diarrhea: Mild","categories":[{"measurements":[{"groupId":"OG000","value":"9.7","lowerLimit":"2.0","upperLimit":"25.8"},{"groupId":"OG001","value":"3.1","lowerLimit":"0.1","upperLimit":"16.2"},{"groupId":"OG002","value":"9.4","lowerLimit":"2.0","upperLimit":"25.0"},{"groupId":"OG003","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG004","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG005","value":"10.0","lowerLimit":"2.1","upperLimit":"26.5"},{"groupId":"OG006","value":"6.3","lowerLimit":"0.8","upperLimit":"20.8"},{"groupId":"OG007","value":"6.7","lowerLimit":"0.8","upperLimit":"22.1"}]}]},{"title":"Diarrhea: Moderate","categories":[{"measurements":[{"groupId":"OG000","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG001","value":"3.1","lowerLimit":"0.1","upperLimit":"16.2"},{"groupId":"OG002","value":"6.3","lowerLimit":"0.8","upperLimit":"20.8"},{"groupId":"OG003","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG004","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG007","value":"6.7","lowerLimit":"0.8","upperLimit":"22.1"}]}]},{"title":"Diarrhea: Severe","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG003","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG004","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG007","value":"0","lowerLimit":"0.0","upperLimit":"11.6"}]}]},{"title":"Headache: Mild","categories":[{"measurements":[{"groupId":"OG000","value":"16.1","lowerLimit":"5.5","upperLimit":"33.7"},{"groupId":"OG001","value":"3.1","lowerLimit":"0.1","upperLimit":"16.2"},{"groupId":"OG002","value":"3.1","lowerLimit":"0.1","upperLimit":"16.2"},{"groupId":"OG003","value":"6.5","lowerLimit":"0.8","upperLimit":"21.4"},{"groupId":"OG004","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG005","value":"16.7","lowerLimit":"5.6","upperLimit":"34.7"},{"groupId":"OG006","value":"25.0","lowerLimit":"11.5","upperLimit":"43.4"},{"groupId":"OG007","value":"6.7","lowerLimit":"0.8","upperLimit":"22.1"}]}]},{"title":"Headache: Moderate","categories":[{"measurements":[{"groupId":"OG000","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG001","value":"6.3","lowerLimit":"0.8","upperLimit":"20.8"},{"groupId":"OG002","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG003","value":"9.7","lowerLimit":"2.0","upperLimit":"25.8"},{"groupId":"OG004","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"9.4","lowerLimit":"2.0","upperLimit":"25.0"},{"groupId":"OG007","value":"0","lowerLimit":"0.0","upperLimit":"11.6"}]}]},{"title":"Headache: Severe","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG003","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG004","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"3.1","lowerLimit":"0.1","upperLimit":"16.2"},{"groupId":"OG007","value":"0","lowerLimit":"0.0","upperLimit":"11.6"}]}]},{"title":"FatigueTtiredness: Mild","categories":[{"measurements":[{"groupId":"OG000","value":"16.1","lowerLimit":"5.5","upperLimit":"33.7"},{"groupId":"OG001","value":"15.6","lowerLimit":"5.3","upperLimit":"32.8"},{"groupId":"OG002","value":"9.4","lowerLimit":"2.0","upperLimit":"25.0"},{"groupId":"OG003","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG004","value":"16.1","lowerLimit":"5.5","upperLimit":"33.7"},{"groupId":"OG005","value":"3.3","lowerLimit":"0.1","upperLimit":"17.2"},{"groupId":"OG006","value":"31.3","lowerLimit":"16.1","upperLimit":"50.0"},{"groupId":"OG007","value":"16.7","lowerLimit":"5.6","upperLimit":"34.7"}]}]},{"title":"Fatigue/Tiredness: Moderate","categories":[{"measurements":[{"groupId":"OG000","value":"6.5","lowerLimit":"0.8","upperLimit":"21.4"},{"groupId":"OG001","value":"3.1","lowerLimit":"0.1","upperLimit":"16.2"},{"groupId":"OG002","value":"18.8","lowerLimit":"7.2","upperLimit":"36.4"},{"groupId":"OG003","value":"25.8","lowerLimit":"11.9","upperLimit":"44.6"},{"groupId":"OG004","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG005","value":"10.0","lowerLimit":"2.1","upperLimit":"26.5"},{"groupId":"OG006","value":"9.4","lowerLimit":"2.0","upperLimit":"25.0"},{"groupId":"OG007","value":"3.3","lowerLimit":"0.1","upperLimit":"17.2"}]}]},{"title":"Fatigue/Tiredness: Severe","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG003","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG004","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"3.1","lowerLimit":"0.1","upperLimit":"16.2"},{"groupId":"OG007","value":"0","lowerLimit":"0.0","upperLimit":"11.6"}]}]},{"title":"Muscle Pain: Mild","categories":[{"measurements":[{"groupId":"OG000","value":"9.7","lowerLimit":"2.0","upperLimit":"25.8"},{"groupId":"OG001","value":"6.3","lowerLimit":"0.8","upperLimit":"20.8"},{"groupId":"OG002","value":"6.3","lowerLimit":"0.8","upperLimit":"20.8"},{"groupId":"OG003","value":"9.7","lowerLimit":"2.0","upperLimit":"25.8"},{"groupId":"OG004","value":"12.9","lowerLimit":"3.6","upperLimit":"29.8"},{"groupId":"OG005","value":"10.0","lowerLimit":"2.1","upperLimit":"26.5"},{"groupId":"OG006","value":"12.5","lowerLimit":"3.5","upperLimit":"29.0"},{"groupId":"OG007","value":"16.7","lowerLimit":"5.6","upperLimit":"34.7"}]}]},{"title":"Muscle Pain: Moderate","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG001","value":"3.1","lowerLimit":"0.1","upperLimit":"16.2"},{"groupId":"OG002","value":"3.1","lowerLimit":"0.1","upperLimit":"16.2"},{"groupId":"OG003","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG004","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG005","value":"6.7","lowerLimit":"0.8","upperLimit":"22.1"},{"groupId":"OG006","value":"6.3","lowerLimit":"0.8","upperLimit":"20.8"},{"groupId":"OG007","value":"3.3","lowerLimit":"0.1","upperLimit":"17.2"}]}]},{"title":"Muscle Pain: Severe","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG003","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG004","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG007","value":"0","lowerLimit":"0.0","upperLimit":"11.6"}]}]},{"title":"Joint Pain: Mild","categories":[{"measurements":[{"groupId":"OG000","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"6.3","lowerLimit":"0.8","upperLimit":"20.8"},{"groupId":"OG003","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG004","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG005","value":"6.7","lowerLimit":"0.8","upperLimit":"22.1"},{"groupId":"OG006","value":"9.4","lowerLimit":"2.0","upperLimit":"25.0"},{"groupId":"OG007","value":"10.0","lowerLimit":"2.1","upperLimit":"26.5"}]}]},{"title":"Joint Pain: Moderate","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG001","value":"3.1","lowerLimit":"0.1","upperLimit":"16.2"},{"groupId":"OG002","value":"9.4","lowerLimit":"2.0","upperLimit":"25.0"},{"groupId":"OG003","value":"3.2","lowerLimit":"0.1","upperLimit":"16.7"},{"groupId":"OG004","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG007","value":"3.3","lowerLimit":"0.1","upperLimit":"17.2"}]}]},{"title":"Joint Pain: Severe","categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG001","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG002","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG003","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG004","value":"0","lowerLimit":"0.0","upperLimit":"11.2"},{"groupId":"OG005","value":"0","lowerLimit":"0.0","upperLimit":"11.6"},{"groupId":"OG006","value":"0","lowerLimit":"0.0","upperLimit":"10.9"},{"groupId":"OG007","value":"0","lowerLimit":"0.0","upperLimit":"11.6"}]}]}]},{"type":"PRIMARY","title":"Primary Cohort: Percentage of Participants With Adverse Events (AEs) Within 1 Month After Vaccination 1","description":"An AE is any untoward medical occurrence in a study participant administered a product or medical device; the event need not necessarily have a causal relationship with the treatment or usage. AEs included both serious and non-serious adverse events.","populationDescription":"Safety population included all participants who received at least 1 dose of the investigational products (RSVpreF or placebo) at Visit 1. Data for this outcome measure was planned to be collected for Primary cohort only.","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"percentage of participants","timeFrame":"Within 1 month after Vaccination 1","groups":[{"id":"OG000","title":"Primary Cohort: RSVpreF 60 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of respiratory syncytial virus stabilized prefusion F subunit (RSVpreF) 60 microgram (mcg) with aluminum hydroxide (Al\\[OH\\]3) by injecting 0.5 milliliter (mL) dose along with single 0.5mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG001","title":"Primary Cohort: RSVpreF 60 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 60 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG002","title":"Primary Cohort: RSVpreF 120 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 120 mcg with Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG003","title":"Primary Cohort: RSVpreF 120 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 120 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG004","title":"Primary Cohort: RSVpreF 240 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG005","title":"Primary Cohort: RSVpreF 240 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG006","title":"Primary Cohort: RSVpreF 240 mcg + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG007","title":"Primary Cohort: Placebo + SIIV","description":"Participants were administered an intramuscular dose of placebo intramuscularly as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"31"},{"groupId":"OG005","value":"30"},{"groupId":"OG006","value":"32"},{"groupId":"OG007","value":"30"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"21.9","lowerLimit":"9.3","upperLimit":"40.0"},{"groupId":"OG001","value":"21.9","lowerLimit":"9.3","upperLimit":"40.0"},{"groupId":"OG002","value":"34.4","lowerLimit":"18.6","upperLimit":"53.2"},{"groupId":"OG003","value":"29.0","lowerLimit":"14.2","upperLimit":"48.0"},{"groupId":"OG004","value":"25.8","lowerLimit":"11.9","upperLimit":"44.6"},{"groupId":"OG005","value":"23.3","lowerLimit":"9.9","upperLimit":"42.3"},{"groupId":"OG006","value":"21.9","lowerLimit":"9.3","upperLimit":"40.0"},{"groupId":"OG007","value":"16.7","lowerLimit":"5.6","upperLimit":"34.7"}]}]}]},{"type":"PRIMARY","title":"Primary Cohort: Percentage of Participants With Medically Attended Adverse Events (MAEs) and Serious Adverse Events (SAEs) Through 12 Months After Vaccination 1","description":"An MAE was defined as a non-serious AE that resulted in an evaluation at a medical facility. A SAE is any untoward medical occurrence at any dose: results in death; is life-threatening (immediate risk of death); requires inpatient hospitalization or prolongation of existing hospitalization; results in persistent or significant disability/incapacity (substantial disruption of the ability to conduct normal life functions); results in congenital anomaly/birth defect.","populationDescription":"Safety population included all participants who received at least 1 dose of the investigational products (RSVpreF or placebo) at Visit 1. Data for this outcome measure was planned to be collected for Primary cohort only.","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"percentage of participants","timeFrame":"Up to 12 months after Vaccination 1","groups":[{"id":"OG000","title":"Primary Cohort: RSVpreF 60 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of respiratory syncytial virus stabilized prefusion F subunit (RSVpreF) 60 microgram (mcg) with aluminum hydroxide (Al\\[OH\\]3) by injecting 0.5 milliliter (mL) dose along with single 0.5mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG001","title":"Primary Cohort: RSVpreF 60 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 60 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG002","title":"Primary Cohort: RSVpreF 120 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 120 mcg with Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG003","title":"Primary Cohort: RSVpreF 120 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 120 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG004","title":"Primary Cohort: RSVpreF 240 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG005","title":"Primary Cohort: RSVpreF 240 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG006","title":"Primary Cohort: RSVpreF 240 mcg + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG007","title":"Primary Cohort: Placebo + SIIV","description":"Participants were administered an intramuscular dose of placebo intramuscularly as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"31"},{"groupId":"OG005","value":"30"},{"groupId":"OG006","value":"32"},{"groupId":"OG007","value":"30"}]}],"classes":[{"title":"MAEs","categories":[{"measurements":[{"groupId":"OG000","value":"46.9","lowerLimit":"29.1","upperLimit":"65.3"},{"groupId":"OG001","value":"59.4","lowerLimit":"40.6","upperLimit":"76.3"},{"groupId":"OG002","value":"46.9","lowerLimit":"29.1","upperLimit":"65.3"},{"groupId":"OG003","value":"51.6","lowerLimit":"33.1","upperLimit":"69.8"},{"groupId":"OG004","value":"54.8","lowerLimit":"36.0","upperLimit":"72.7"},{"groupId":"OG005","value":"60.0","lowerLimit":"40.6","upperLimit":"77.3"},{"groupId":"OG006","value":"50.0","lowerLimit":"31.9","upperLimit":"68.1"},{"groupId":"OG007","value":"50.0","lowerLimit":"31.3","upperLimit":"68.7"}]}]},{"title":"SAEs","categories":[{"measurements":[{"groupId":"OG000","value":"6.3","lowerLimit":"0.8","upperLimit":"20.8"},{"groupId":"OG001","value":"12.5","lowerLimit":"3.5","upperLimit":"29.0"},{"groupId":"OG002","value":"12.5","lowerLimit":"3.5","upperLimit":"29.0"},{"groupId":"OG003","value":"12.9","lowerLimit":"3.6","upperLimit":"29.8"},{"groupId":"OG004","value":"16.1","lowerLimit":"5.5","upperLimit":"33.7"},{"groupId":"OG005","value":"13.3","lowerLimit":"3.8","upperLimit":"30.7"},{"groupId":"OG006","value":"12.5","lowerLimit":"3.5","upperLimit":"29.0"},{"groupId":"OG007","value":"10.0","lowerLimit":"2.1","upperLimit":"26.5"}]}]}]},{"type":"SECONDARY","title":"Primary Cohort: Geometric Mean Titers (GMT) of Respiratory Syncytial Virus Subgroup A (RSV A) and Respiratory Syncytial Virus Subgroup B (RSV B) Neutralizing Antibodies Before and 1 Month After Vaccination 1","description":"GMTs of RSV A and RSV B antigens were measured using neutralizing assay. Titers above the lower limit of quantitation (LLOQ) were considered accurate and their quantitated values were reported. The neutralizing titer LLOQ values were: A = 50 and B = 70. Assay results below the LLOQ were set to 0.5 × LLOQ.","populationDescription":"Evaluable immunogenicity population: eligible participants who received both SIIV and RSV vaccinations or SIIV and placebo as randomized, had blood drawn within 27-42 days after Visit 1 pre-specified time frames at 1-month post-vaccination follow-up visit, had at least 1 valid, determinate assay result for proposed analysis, had no major protocol violations. Number Analyzed= participants evaluable for each row. Data for this outcome measure was planned to be collected for Primary cohort only.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"titers","timeFrame":"Before vaccination and 1 Month after Vaccination 1","groups":[{"id":"OG000","title":"Primary Cohort: RSVpreF 60 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of respiratory syncytial virus stabilized prefusion F subunit (RSVpreF) 60 microgram (mcg) with aluminum hydroxide (Al\\[OH\\]3) by injecting 0.5 milliliter (mL) dose along with single 0.5mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG001","title":"Primary Cohort: RSVpreF 60 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 60 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG002","title":"Primary Cohort: RSVpreF 120 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 120 mcg with Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG003","title":"Primary Cohort: RSVpreF 120 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 120 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG004","title":"Primary Cohort: RSVpreF 240 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG005","title":"Primary Cohort: RSVpreF 240 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG006","title":"Primary Cohort: RSVpreF 240 mcg + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG007","title":"Primary Cohort: Placebo + SIIV","description":"Participants were administered an intramuscular dose of placebo intramuscularly as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"31"},{"groupId":"OG005","value":"29"},{"groupId":"OG006","value":"31"},{"groupId":"OG007","value":"30"}]}],"classes":[{"title":"RSV A: Before Vaccination 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"31"},{"groupId":"OG005","value":"29"},{"groupId":"OG006","value":"31"},{"groupId":"OG007","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2113","lowerLimit":"1610.6","upperLimit":"2772.5"},{"groupId":"OG001","value":"2592","lowerLimit":"1932.3","upperLimit":"3477.8"},{"groupId":"OG002","value":"2234","lowerLimit":"1591.1","upperLimit":"3136.5"},{"groupId":"OG003","value":"2395","lowerLimit":"1817.9","upperLimit":"3155.4"},{"groupId":"OG004","value":"2333","lowerLimit":"1779.8","upperLimit":"3057.1"},{"groupId":"OG005","value":"2061","lowerLimit":"1600.2","upperLimit":"2653.4"},{"groupId":"OG006","value":"2243","lowerLimit":"1696.4","upperLimit":"2966.8"},{"groupId":"OG007","value":"2093","lowerLimit":"1509.0","upperLimit":"2903.8"}]}]},{"title":"RSV A: 1 Month After Vaccination 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"31"},{"groupId":"OG005","value":"29"},{"groupId":"OG006","value":"31"},{"groupId":"OG007","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"15158","lowerLimit":"10503.8","upperLimit":"21875.0"},{"groupId":"OG001","value":"12385","lowerLimit":"9555.6","upperLimit":"16051.2"},{"groupId":"OG002","value":"17806","lowerLimit":"12893.3","upperLimit":"24590.4"},{"groupId":"OG003","value":"15492","lowerLimit":"11012.7","upperLimit":"21793.6"},{"groupId":"OG004","value":"18045","lowerLimit":"12589.5","upperLimit":"25865.5"},{"groupId":"OG005","value":"23929","lowerLimit":"18242.8","upperLimit":"31386.8"},{"groupId":"OG006","value":"23833","lowerLimit":"17799.2","upperLimit":"31912.0"},{"groupId":"OG007","value":"1823","lowerLimit":"1376.5","upperLimit":"2415.2"}]}]},{"title":"RSV B: Before Vaccination 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"31"},{"groupId":"OG005","value":"29"},{"groupId":"OG006","value":"31"},{"groupId":"OG007","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1786","lowerLimit":"1383.3","upperLimit":"2305.3"},{"groupId":"OG001","value":"2116","lowerLimit":"1526.7","upperLimit":"2933.7"},{"groupId":"OG002","value":"1728","lowerLimit":"1271.9","upperLimit":"2346.4"},{"groupId":"OG003","value":"2021","lowerLimit":"1451.8","upperLimit":"2812.2"},{"groupId":"OG004","value":"1884","lowerLimit":"1337.0","upperLimit":"2655.9"},{"groupId":"OG005","value":"1844","lowerLimit":"1417.5","upperLimit":"2398.8"},{"groupId":"OG006","value":"1580","lowerLimit":"1210.9","upperLimit":"2061.1"},{"groupId":"OG007","value":"1677","lowerLimit":"1156.2","upperLimit":"2433.0"}]}]},{"title":"RSV B: 1 Month After Vaccination 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"31"},{"groupId":"OG005","value":"29"},{"groupId":"OG006","value":"31"},{"groupId":"OG007","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"15182","lowerLimit":"9785.1","upperLimit":"23555.6"},{"groupId":"OG001","value":"9694","lowerLimit":"7396.8","upperLimit":"12705.8"},{"groupId":"OG002","value":"14436","lowerLimit":"10196.9","upperLimit":"20436.9"},{"groupId":"OG003","value":"12781","lowerLimit":"8571.0","upperLimit":"19058.7"},{"groupId":"OG004","value":"18205","lowerLimit":"12574.4","upperLimit":"26356.6"},{"groupId":"OG005","value":"20777","lowerLimit":"15034.9","upperLimit":"28711.0"},{"groupId":"OG006","value":"22249","lowerLimit":"15715.7","upperLimit":"31497.5"},{"groupId":"OG007","value":"1617","lowerLimit":"1139.6","upperLimit":"2294.9"}]}]}]},{"type":"SECONDARY","title":"Primary Cohort: Hemagglutination Inhibition Assay (HAI) and Neutralizing Antibody Geometric Mean Titers for All Strains Following the Seasonal Inactivated Influenza Vaccine (SIIV) Before and 1 Month After Vaccination 1","description":"The HAI and neutralizing titer LLOQ value for each strain was 1:10. Assay results below the LLOQ were set to 0.5 × LLOQ. The analysis was performed on following strains: H1N1 A/Michigan, H3N2 A/Brisbane, B/Phuket for HAI and H3N2/Brisbane for neutralizing assay.","populationDescription":"Evaluable immunogenicity population: participants who received both SIIV and RSV vaccinations or SIIV and placebo as randomized, had blood drawn within 27-42 days after Visit 1 pre-specified time frames at 1-month post-vaccination follow-up visit, had at least 1 valid, determinate assay result for analysis, had no major protocol violations. Number Analyzed = participants evaluable for each specified row. Data for this outcome was planned to be collected for Primary cohort only.","reportingStatus":"POSTED","paramType":"GEOMETRIC_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"titers","timeFrame":"Before vaccination and 1 Month after Vaccination 1","groups":[{"id":"OG000","title":"Primary Cohort: RSVpreF 60 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of respiratory syncytial virus stabilized prefusion F subunit (RSVpreF) 60 microgram (mcg) with aluminum hydroxide (Al\\[OH\\]3) by injecting 0.5 milliliter (mL) dose along with single 0.5mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG001","title":"Primary Cohort: RSVpreF 60 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 60 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG002","title":"Primary Cohort: RSVpreF 120 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 120 mcg with Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG003","title":"Primary Cohort: RSVpreF 120 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 120 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG004","title":"Primary Cohort: RSVpreF 240 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG005","title":"Primary Cohort: RSVpreF 240 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG006","title":"Primary Cohort: RSVpreF 240 mcg + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."},{"id":"OG007","title":"Primary Cohort: Placebo + SIIV","description":"Participants were administered an intramuscular dose of placebo intramuscularly as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12."}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"31"},{"groupId":"OG005","value":"29"},{"groupId":"OG006","value":"31"},{"groupId":"OG007","value":"30"}]}],"classes":[{"title":"HAI: H1N1 A/Michigan: Before Vaccination 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"31"},{"groupId":"OG005","value":"29"},{"groupId":"OG006","value":"31"},{"groupId":"OG007","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"47.9","lowerLimit":"31.69","upperLimit":"72.26"},{"groupId":"OG001","value":"42.8","lowerLimit":"27.81","upperLimit":"65.78"},{"groupId":"OG002","value":"29.5","lowerLimit":"19.03","upperLimit":"45.84"},{"groupId":"OG003","value":"35.8","lowerLimit":"22.14","upperLimit":"57.77"},{"groupId":"OG004","value":"37.2","lowerLimit":"22.99","upperLimit":"60.19"},{"groupId":"OG005","value":"31.9","lowerLimit":"18.31","upperLimit":"55.48"},{"groupId":"OG006","value":"38.3","lowerLimit":"27.20","upperLimit":"53.80"},{"groupId":"OG007","value":"35.4","lowerLimit":"20.37","upperLimit":"61.60"}]}]},{"title":"HAI: H1N1 A/Michigan: 1 Month After Vaccination 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"31"},{"groupId":"OG005","value":"29"},{"groupId":"OG006","value":"31"},{"groupId":"OG007","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"121.5","lowerLimit":"84.37","upperLimit":"175.11"},{"groupId":"OG001","value":"114.4","lowerLimit":"79.95","upperLimit":"163.60"},{"groupId":"OG002","value":"102.1","lowerLimit":"69.15","upperLimit":"150.65"},{"groupId":"OG003","value":"141.5","lowerLimit":"90.54","upperLimit":"221.13"},{"groupId":"OG004","value":"143.9","lowerLimit":"91.81","upperLimit":"225.51"},{"groupId":"OG005","value":"100.4","lowerLimit":"74.68","upperLimit":"134.96"},{"groupId":"OG006","value":"118.3","lowerLimit":"84.12","upperLimit":"166.40"},{"groupId":"OG007","value":"149.3","lowerLimit":"104.93","upperLimit":"212.40"}]}]},{"title":"HAI: H3N2 A/Brisbane: Before Vaccination 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"31"},{"groupId":"OG005","value":"29"},{"groupId":"OG006","value":"31"},{"groupId":"OG007","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"121.6","lowerLimit":"67.92","upperLimit":"217.54"},{"groupId":"OG001","value":"143.9","lowerLimit":"90.99","upperLimit":"227.52"},{"groupId":"OG002","value":"57.8","lowerLimit":"35.11","upperLimit":"95.19"},{"groupId":"OG003","value":"80.9","lowerLimit":"53.49","upperLimit":"122.38"},{"groupId":"OG004","value":"102.3","lowerLimit":"61.32","upperLimit":"170.69"},{"groupId":"OG005","value":"90.7","lowerLimit":"53.21","upperLimit":"154.57"},{"groupId":"OG006","value":"121.7","lowerLimit":"87.32","upperLimit":"169.55"},{"groupId":"OG007","value":"76.8","lowerLimit":"45.79","upperLimit":"128.87"}]}]},{"title":"HAI: H3N2 A/Brisbane: 1 Month After Vaccination 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"31"},{"groupId":"OG005","value":"29"},{"groupId":"OG006","value":"31"},{"groupId":"OG007","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"297.9","lowerLimit":"197.30","upperLimit":"449.64"},{"groupId":"OG001","value":"372.4","lowerLimit":"221.98","upperLimit":"624.70"},{"groupId":"OG002","value":"238.9","lowerLimit":"167.42","upperLimit":"340.78"},{"groupId":"OG003","value":"251.6","lowerLimit":"163.84","upperLimit":"386.49"},{"groupId":"OG004","value":"327.2","lowerLimit":"208.41","upperLimit":"513.80"},{"groupId":"OG005","value":"258.1","lowerLimit":"174.20","upperLimit":"382.29"},{"groupId":"OG006","value":"286.2","lowerLimit":"201.75","upperLimit":"405.87"},{"groupId":"OG007","value":"321.8","lowerLimit":"221.41","upperLimit":"467.83"}]}]},{"title":"HAI: B/Phuket: Before Vaccination 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"31"},{"groupId":"OG005","value":"29"},{"groupId":"OG006","value":"31"},{"groupId":"OG007","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"8.7","lowerLimit":"6.37","upperLimit":"11.78"},{"groupId":"OG001","value":"8.4","lowerLimit":"6.68","upperLimit":"10.59"},{"groupId":"OG002","value":"6.6","lowerLimit":"5.61","upperLimit":"7.82"},{"groupId":"OG003","value":"7.9","lowerLimit":"6.31","upperLimit":"9.79"},{"groupId":"OG004","value":"8.6","lowerLimit":"6.57","upperLimit":"11.25"},{"groupId":"OG005","value":"7.3","lowerLimit":"5.55","upperLimit":"9.69"},{"groupId":"OG006","value":"9.1","lowerLimit":"6.82","upperLimit":"12.11"},{"groupId":"OG007","value":"7.5","lowerLimit":"5.74","upperLimit":"9.77"}]}]},{"title":"HAI: B/Phuket: 1 Month After Vaccination 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"31"},{"groupId":"OG005","value":"29"},{"groupId":"OG006","value":"31"},{"groupId":"OG007","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"12.3","lowerLimit":"8.99","upperLimit":"16.90"},{"groupId":"OG001","value":"11.2","lowerLimit":"8.41","upperLimit":"14.92"},{"groupId":"OG002","value":"10.2","lowerLimit":"8.03","upperLimit":"13.00"},{"groupId":"OG003","value":"12.2","lowerLimit":"8.62","upperLimit":"17.15"},{"groupId":"OG004","value":"14.4","lowerLimit":"10.31","upperLimit":"20.05"},{"groupId":"OG005","value":"14.7","lowerLimit":"10.21","upperLimit":"21.30"},{"groupId":"OG006","value":"15.5","lowerLimit":"10.86","upperLimit":"22.02"},{"groupId":"OG007","value":"15.2","lowerLimit":"10.25","upperLimit":"22.68"}]}]},{"title":"Neutralizing assay: H3N2/Brisbane: Before Vaccination 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"31"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"31"},{"groupId":"OG005","value":"29"},{"groupId":"OG006","value":"31"},{"groupId":"OG007","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"12.4","lowerLimit":"9.06","upperLimit":"16.97"},{"groupId":"OG001","value":"15.5","lowerLimit":"11.94","upperLimit":"20.02"},{"groupId":"OG002","value":"10.2","lowerLimit":"8.09","upperLimit":"12.90"},{"groupId":"OG003","value":"9.3","lowerLimit":"7.76","upperLimit":"11.27"},{"groupId":"OG004","value":"12.4","lowerLimit":"9.03","upperLimit":"16.93"},{"groupId":"OG005","value":"10.1","lowerLimit":"7.84","upperLimit":"13.06"},{"groupId":"OG006","value":"12.2","lowerLimit":"10.16","upperLimit":"14.71"},{"groupId":"OG007","value":"8.7","lowerLimit":"6.92","upperLimit":"10.95"}]}]},{"title":"Neutralizing assay: H3N2/Brisbane: 1 Month After Vaccination 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"32"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"31"},{"groupId":"OG005","value":"29"},{"groupId":"OG006","value":"31"},{"groupId":"OG007","value":"30"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"27.3","lowerLimit":"19.24","upperLimit":"38.70"},{"groupId":"OG001","value":"27.4","lowerLimit":"18.43","upperLimit":"40.66"},{"groupId":"OG002","value":"19.1","lowerLimit":"14.63","upperLimit":"25.06"},{"groupId":"OG003","value":"21.4","lowerLimit":"16.08","upperLimit":"28.44"},{"groupId":"OG004","value":"22.1","lowerLimit":"16.11","upperLimit":"30.36"},{"groupId":"OG005","value":"21.2","lowerLimit":"16.15","upperLimit":"27.90"},{"groupId":"OG006","value":"21.9","lowerLimit":"16.82","upperLimit":"28.44"},{"groupId":"OG007","value":"26.7","lowerLimit":"18.74","upperLimit":"38.00"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"0","timeFrame":"Local reactions and systemic events: within 14 days after vaccination Other AEs: within one month after vaccination; SAEs: Day 1 up to 12 Months for Primary Cohort; Day 1 up to 6 Months for Month-0, Month-2 Cohort","description":"Same event may appear as both an AE and SAE. However, what is presented are distinct events. An event may be categorized as serious in 1 participant and as non-serious in another, or a participant may have experienced both a serious and non-serious event. Safety population included all participants who received at least 1 dose of the investigational products (RSVpreF or placebo) at Visit 1.","eventGroups":[{"id":"EG000","title":"Primary Cohort: RSVpreF 60 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of respiratory syncytial virus stabilized prefusion F subunit (RSVpreF) 60 microgram (mcg) with aluminum hydroxide (Al\\[OH\\]3) by injecting 0.5 milliliter (mL) dose along with single 0.5mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12.","deathsNumAffected":0,"deathsNumAtRisk":32,"seriousNumAffected":2,"seriousNumAtRisk":32,"otherNumAffected":17,"otherNumAtRisk":32},{"id":"EG001","title":"Primary Cohort: RSVpreF 60 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 60 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12.","deathsNumAffected":0,"deathsNumAtRisk":32,"seriousNumAffected":4,"seriousNumAtRisk":32,"otherNumAffected":17,"otherNumAtRisk":32},{"id":"EG002","title":"Primary Cohort: RSVpreF 120 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 120 mcg with Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12.","deathsNumAffected":0,"deathsNumAtRisk":32,"seriousNumAffected":4,"seriousNumAtRisk":32,"otherNumAffected":21,"otherNumAtRisk":32},{"id":"EG003","title":"Primary Cohort: RSVpreF 120 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 120 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12.","deathsNumAffected":0,"deathsNumAtRisk":31,"seriousNumAffected":4,"seriousNumAtRisk":31,"otherNumAffected":21,"otherNumAtRisk":31},{"id":"EG004","title":"Primary Cohort: RSVpreF 240 mcg + Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12.","deathsNumAffected":0,"deathsNumAtRisk":31,"seriousNumAffected":5,"seriousNumAtRisk":31,"otherNumAffected":17,"otherNumAtRisk":31},{"id":"EG005","title":"Primary Cohort: RSVpreF 240 mcg + CpG/Al(OH)3 + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with CpG/Al(OH)3 as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12.","deathsNumAffected":1,"deathsNumAtRisk":30,"seriousNumAffected":4,"seriousNumAtRisk":30,"otherNumAffected":12,"otherNumAtRisk":30},{"id":"EG006","title":"Primary Cohort: RSVpreF 240 mcg + SIIV","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12.","deathsNumAffected":0,"deathsNumAtRisk":32,"seriousNumAffected":4,"seriousNumAtRisk":32,"otherNumAffected":25,"otherNumAtRisk":32},{"id":"EG007","title":"Primary Cohort: Placebo + SIIV","description":"Participants were administered an intramuscular dose of placebo intramuscularly as 0.5-mL injection along with single 0.5 mL intramuscular dose of SIIV on Day 1. Participants were followed-up through Month 12.","deathsNumAffected":0,"deathsNumAtRisk":30,"seriousNumAffected":3,"seriousNumAtRisk":30,"otherNumAffected":14,"otherNumAtRisk":30},{"id":"EG008","title":"Month-0, Month-2 Cohort: RSVpreF 240 mcg + CpG/Al(OH)3","description":"Participants were administered an intramuscular dose of RSVpreF 240 mcg with CpG/Al(OH)3 as 0.5-mL injection on Day 1 Month 0 (Vaccination 1) and Month 2 (Vaccination 2: 54 to 66 Days after Vaccination 1). Participants were followed up through 6 months after Vaccination 2.","deathsNumAffected":0,"deathsNumAtRisk":32,"seriousNumAffected":6,"seriousNumAtRisk":32,"otherNumAffected":28,"otherNumAtRisk":32},{"id":"EG009","title":"Month-0, Month-2 Cohort: Placebo","description":"Participants were administered an intramuscular dose of placebo as 0.5-mL injection on Day 1 Month 0 (Vaccination 1) and Month 2 (Vaccination 2: 54 to 66 Days after Vaccination 1). Participants were followed up through 6 months after Vaccination 2.","deathsNumAffected":0,"deathsNumAtRisk":31,"seriousNumAffected":5,"seriousNumAtRisk":31,"otherNumAffected":23,"otherNumAtRisk":31}],"seriousEvents":[{"term":"Lymphadenopathy","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":1,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Acute myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":1,"numAtRisk":31}]},{"term":"Arrhythmia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":1,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Atrial fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":1,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":1,"numAtRisk":31}]},{"term":"Bradycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":1,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Coronary artery disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Coronary artery occlusion","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":1,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Vertigo","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":1,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":1,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Colitis ischaemic","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":1,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":1,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Femoral hernia incarcerated","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":1,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Gastrooesophageal reflux disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":1,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Large intestine polyp","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":1,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":1,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Pancreatitis acute","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Rectal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":1,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Anaphylactic reaction","organSystem":"Immune system disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":1,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Diverticulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Escherichia sepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":1,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Medical device site joint infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":1,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Urosepsis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":1,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Facial bones fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":1,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Limb injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":1,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Post procedural haemorrhage","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":1,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Road traffic accident","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Skin laceration","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Diabetic ketoacidosis","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":1,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Cervical spinal stenosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":1,"numAtRisk":31}]},{"term":"Intervertebral disc protrusion","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":1,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Musculoskeletal chest pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Osteoarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":1,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Clear cell renal cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Endometrial cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Gastrooesophageal cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":1,"numAtRisk":31}]},{"term":"Oesophageal squamous cell carcinoma metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":1,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Prostate cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":1,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Triple negative breast cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":1,"numAtRisk":31}]},{"term":"Morton's neuralgia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":1,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":1,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Device breakage","organSystem":"Product Issues","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":1,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Anxiety","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Depression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Bladder disorder","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":1,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Nephrolithiasis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Ureterolithiasis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Asthma","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Atelectasis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":1,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Pulmonary embolism","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":1,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]}],"otherEvents":[{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Vertigo","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":1,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":1,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Fatigue (FATIGUE)","organSystem":"General disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":32},{"groupId":"EG001","numAffected":6,"numAtRisk":32},{"groupId":"EG002","numAffected":9,"numAtRisk":32},{"groupId":"EG003","numAffected":9,"numAtRisk":31},{"groupId":"EG004","numAffected":6,"numAtRisk":31},{"groupId":"EG005","numAffected":4,"numAtRisk":30},{"groupId":"EG006","numAffected":14,"numAtRisk":32},{"groupId":"EG007","numAffected":6,"numAtRisk":30},{"groupId":"EG008","numAffected":12,"numAtRisk":32},{"groupId":"EG009","numAffected":13,"numAtRisk":31}]},{"term":"Influenza like illness","organSystem":"General disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":1,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Injection site erythema","organSystem":"General disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Injection site erythema (REDNESS)","organSystem":"General disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":1,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":3,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":2,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":5,"numAtRisk":32},{"groupId":"EG009","numAffected":1,"numAtRisk":31}]},{"term":"Injection site pain","organSystem":"General disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":1,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Injection site pain (PAIN AT INJECTION SITE)","organSystem":"General disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":32},{"groupId":"EG001","numAffected":10,"numAtRisk":32},{"groupId":"EG002","numAffected":1,"numAtRisk":32},{"groupId":"EG003","numAffected":9,"numAtRisk":31},{"groupId":"EG004","numAffected":7,"numAtRisk":31},{"groupId":"EG005","numAffected":5,"numAtRisk":30},{"groupId":"EG006","numAffected":6,"numAtRisk":32},{"groupId":"EG007","numAffected":3,"numAtRisk":30},{"groupId":"EG008","numAffected":12,"numAtRisk":32},{"groupId":"EG009","numAffected":4,"numAtRisk":31}]},{"term":"Injection site reaction","organSystem":"General disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":1,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Injection site swelling (SWELLING)","organSystem":"General disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":32},{"groupId":"EG002","numAffected":1,"numAtRisk":32},{"groupId":"EG003","numAffected":1,"numAtRisk":31},{"groupId":"EG004","numAffected":1,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":1,"numAtRisk":30},{"groupId":"EG008","numAffected":4,"numAtRisk":32},{"groupId":"EG009","numAffected":1,"numAtRisk":31}]},{"term":"Peripheral swelling","organSystem":"General disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Pyrexia (FEVER)","organSystem":"General disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":3,"numAtRisk":32},{"groupId":"EG003","numAffected":1,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":3,"numAtRisk":31}]},{"term":"Vaccination site pain","organSystem":"General disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":1,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":2,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Diarrhoea (DIARRHEA)","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":4,"numAtRisk":32},{"groupId":"EG001","numAffected":2,"numAtRisk":32},{"groupId":"EG002","numAffected":5,"numAtRisk":32},{"groupId":"EG003","numAffected":2,"numAtRisk":31},{"groupId":"EG004","numAffected":1,"numAtRisk":31},{"groupId":"EG005","numAffected":3,"numAtRisk":30},{"groupId":"EG006","numAffected":2,"numAtRisk":32},{"groupId":"EG007","numAffected":4,"numAtRisk":30},{"groupId":"EG008","numAffected":2,"numAtRisk":32},{"groupId":"EG009","numAffected":4,"numAtRisk":31}]},{"term":"Diverticulum","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Dry mouth","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":1,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Gastrooesophageal reflux disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":1,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Nausea (NAUSEA)","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":32},{"groupId":"EG002","numAffected":1,"numAtRisk":32},{"groupId":"EG003","numAffected":2,"numAtRisk":31},{"groupId":"EG004","numAffected":3,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":2,"numAtRisk":32},{"groupId":"EG007","numAffected":3,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":4,"numAtRisk":31}]},{"term":"Rectal polyp","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":1,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Bile duct stone","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":1,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Bronchitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Giardiasis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Lower respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Nasopharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":1,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":1,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Parainfluenzae virus infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":1,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":1,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":1,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":2,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":1,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":1,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":1,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":1,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":4,"numAtRisk":31}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":1,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Viral diarrhoea","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":1,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Viral infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Viral upper respiratory tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":32},{"groupId":"EG002","numAffected":2,"numAtRisk":32},{"groupId":"EG003","numAffected":1,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":1,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Arthropod sting","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":1,"numAtRisk":31}]},{"term":"Fall","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Head injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Ligament sprain","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":1,"numAtRisk":31}]},{"term":"Limb injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":2,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Meniscus injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":1,"numAtRisk":31}]},{"term":"Muscle injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":1,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Tendon rupture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":1,"numAtRisk":31}]},{"term":"Haemoglobin decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":1,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Gout","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":1,"numAtRisk":31}]},{"term":"Iron deficiency","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Arthralgia (JOINT PAIN)","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":32},{"groupId":"EG002","numAffected":5,"numAtRisk":32},{"groupId":"EG003","numAffected":2,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":2,"numAtRisk":30},{"groupId":"EG006","numAffected":3,"numAtRisk":32},{"groupId":"EG007","numAffected":4,"numAtRisk":30},{"groupId":"EG008","numAffected":4,"numAtRisk":32},{"groupId":"EG009","numAffected":7,"numAtRisk":31}]},{"term":"Degenerative bone disease","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":1,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Joint swelling","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Muscle spasms","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":1,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Myalgia (MUSCLE PAIN)","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":32},{"groupId":"EG001","numAffected":3,"numAtRisk":32},{"groupId":"EG002","numAffected":3,"numAtRisk":32},{"groupId":"EG003","numAffected":4,"numAtRisk":31},{"groupId":"EG004","numAffected":5,"numAtRisk":31},{"groupId":"EG005","numAffected":5,"numAtRisk":30},{"groupId":"EG006","numAffected":6,"numAtRisk":32},{"groupId":"EG007","numAffected":6,"numAtRisk":30},{"groupId":"EG008","numAffected":6,"numAtRisk":32},{"groupId":"EG009","numAffected":6,"numAtRisk":31}]},{"term":"Neck pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":1,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Osteoarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":32},{"groupId":"EG002","numAffected":1,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Osteopenia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":1,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Temporomandibular joint syndrome","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":1,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Tendon disorder","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":1,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Tendonitis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":1,"numAtRisk":31}]},{"term":"Malignant melanoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Malignant melanoma in situ","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Melanocytic naevus","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":1,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Seborrhoeic keratosis","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":1,"numAtRisk":31}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":1,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":2,"numAtRisk":31}]},{"term":"Headache (HEADACHE)","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":32},{"groupId":"EG001","numAffected":3,"numAtRisk":32},{"groupId":"EG002","numAffected":1,"numAtRisk":32},{"groupId":"EG003","numAffected":6,"numAtRisk":31},{"groupId":"EG004","numAffected":2,"numAtRisk":31},{"groupId":"EG005","numAffected":5,"numAtRisk":30},{"groupId":"EG006","numAffected":12,"numAtRisk":32},{"groupId":"EG007","numAffected":2,"numAtRisk":30},{"groupId":"EG008","numAffected":5,"numAtRisk":32},{"groupId":"EG009","numAffected":9,"numAtRisk":31}]},{"term":"Presyncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Transient ischaemic attack","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":1,"numAtRisk":31}]},{"term":"Confusional state","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Dysuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":1,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":1,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Asthma","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":1,"numAtRisk":31}]},{"term":"Cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":1,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":1,"numAtRisk":31}]},{"term":"Nasal congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":1,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Nasal discomfort","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":1,"numAtRisk":31}]},{"term":"Oropharyngeal pain","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":1,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Productive cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":1,"numAtRisk":31}]},{"term":"Rhinorrhoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":1,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Sinus congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":1,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Actinic keratosis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":1,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":1,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Dermatitis contact","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":1,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Drug eruption","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Dry skin","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":32},{"groupId":"EG001","numAffected":1,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Erythema","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":1,"numAtRisk":31}]},{"term":"Pruritus","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":1,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Rash","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Cataract operation","organSystem":"Surgical and medical procedures","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":1,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Skin neoplasm excision","organSystem":"Surgical and medical procedures","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Tooth extraction","organSystem":"Surgical and medical procedures","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":1,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":0,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]},{"term":"Orthostatic hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA v23.1","assessmentType":"NON_SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":32},{"groupId":"EG001","numAffected":0,"numAtRisk":32},{"groupId":"EG002","numAffected":0,"numAtRisk":32},{"groupId":"EG003","numAffected":0,"numAtRisk":31},{"groupId":"EG004","numAffected":0,"numAtRisk":31},{"groupId":"EG005","numAffected":0,"numAtRisk":30},{"groupId":"EG006","numAffected":0,"numAtRisk":32},{"groupId":"EG007","numAffected":0,"numAtRisk":30},{"groupId":"EG008","numAffected":1,"numAtRisk":32},{"groupId":"EG009","numAffected":0,"numAtRisk":31}]}]},"moreInfoModule":{"limitationsAndCaveats":{"description":"Study follow up of the Month-0, Month-2 cohort was terminated early due to sponsor decision, with all participants followed up through 6 months after Vaccination 2."},"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"Pfizer has the right to review disclosures, requesting a delay of less than 60 days. Investigator will postpone single center publications until after disclosure of pooled data (all sites), less than 12 months from study completion/termination at all participating sites. Investigator may not disclose previously undisclosed confidential information other than study results."},"pointOfContact":{"title":"Pfizer ClinicalTrials.gov Call Center","organization":"Pfizer Inc.","email":"ClinicalTrials.gov_Inquiries@pfizer.com","phone":"1-800-718-1021"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot","hasProtocol":true,"hasSap":false,"hasIcf":false,"label":"Study Protocol","date":"2019-08-22","uploadDate":"2021-06-21T12:01","filename":"Prot_000.pdf","size":3503116},{"typeAbbrev":"SAP","hasProtocol":false,"hasSap":true,"hasIcf":false,"label":"Statistical Analysis Plan","date":"2020-06-09","uploadDate":"2021-06-21T12:01","filename":"SAP_001.pdf","size":4243907}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-11-09","submissionTracking":{"firstMcpInfo":{"postDateStruct":{"date":"2021-07-13","type":"ACTUAL"}}}},"conditionBrowseModule":{"meshes":[{"id":"D012141","term":"Respiratory Tract Infections"}],"ancestors":[{"id":"D007239","term":"Infections"},{"id":"D012140","term":"Respiratory Tract Diseases"}]}},"hasResults":true}